1294 related articles for article (PubMed ID: 21703433)
1. [Attention deficit disorder: multidisciplinary observational study over 1 year].
Chambry J; Billard C; Guinard M; Lacaze E; Idiart ME; Delteil-Pinton F; Cohen de Lara A
Encephale; 2011 Jun; 37(3):180-90. PubMed ID: 21703433
[TBL] [Abstract][Full Text] [Related]
2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
3. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
[TBL] [Abstract][Full Text] [Related]
4. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder.
Huang YS; Chao CC; Wu YY; Chen YY; Chen CK
Psychiatry Clin Neurosci; 2007 Jun; 61(3):219-25. PubMed ID: 17472588
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
7. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
8. When does it end? Attention-deficit/hyperactivity disorder in the middle aged and older populations.
Manor I; Rozen S; Zemishlani Z; Weizman A; Zalsman G
Clin Neuropharmacol; 2011; 34(4):148-54. PubMed ID: 21738027
[TBL] [Abstract][Full Text] [Related]
9. Effect of methylphenidate on Stroop Color-Word task performance in children with attention deficit hyperactivity disorder.
Langleben DD; Monterosso J; Elman I; Ash B; Krikorian G; Austin G
Psychiatry Res; 2006 Mar; 141(3):315-20. PubMed ID: 16516306
[TBL] [Abstract][Full Text] [Related]
10. A pilot study: differential effects of methylphenidate-OROS on working memory and attention functions in children with attention-deficit/hyperactivity disorder with and without behavioural comorbidities.
Rubio B; Hernández S; Verche E; Martín R; González-Pérez P
Atten Defic Hyperact Disord; 2011 Mar; 3(1):13-20. PubMed ID: 21432614
[TBL] [Abstract][Full Text] [Related]
11. Executive impairment determines ADHD medication response: implications for academic achievement.
Hale JB; Reddy LA; Semrud-Clikeman M; Hain LA; Whitaker J; Morley J; Lawrence K; Smith A; Jones N
J Learn Disabil; 2011; 44(2):196-212. PubMed ID: 21383110
[TBL] [Abstract][Full Text] [Related]
12. [The clinical semiology of attention deficit hyperactivity disorder according to age, and the effectiveness of treatments at different ages].
García-Pérez A; Expósito-Torrejón J; Martínez-Granero MA; Quintanar-Rioja A; Bonet-Serra B
Rev Neurol; 2005 Nov 1-15; 41(9):517-24. PubMed ID: 16254857
[TBL] [Abstract][Full Text] [Related]
13. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
Fallu A; Richard C; Prinzo R; Binder C
Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
[TBL] [Abstract][Full Text] [Related]
14. [The effects of methylphenidate on various components of visual attention in children with attention-deficit hyperactivity disorder].
Durukan I; Türkbay T; Cöngöloğlu A
Turk Psikiyatri Derg; 2008; 19(4):358-64. PubMed ID: 19110977
[TBL] [Abstract][Full Text] [Related]
15. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
16. [Supervised off-label prescribing of methylphenidate in adult ADHD].
Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
18. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
Rhodes SM; Coghill DR; Matthews K
J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
[TBL] [Abstract][Full Text] [Related]
19. Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHD.
Robison RJ; Reimherr FW; Gale PD; Marchant BK; Williams ED; Soni P; Halls C; Strong RE
Ann Clin Psychiatry; 2010 May; 22(2):94-102. PubMed ID: 20445836
[TBL] [Abstract][Full Text] [Related]
20. [Methylphenidate and sleep: Results of a multicentre study on a population of children with attention deficit hyperactivity disorder].
Tomás Vila M; Aleu Pérez-Gramunt M; Beseler Soto B; Benac Prefasi M; Pantoja Martínez J; Pitarch Castellano I
An Pediatr (Barc); 2010 Aug; 73(2):78-83. PubMed ID: 20605120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
